Ask about the actual preparation
FDA, the Food and Drug Administration, handles federal drug review. Compounding is preparing a medicine rather than supplying a manufacturer’s finished product. Active ingredient means the medicine’s working component.
For BPC-157, FDA has little or no information about safety in people for the proposed ways of taking it. Its wider peptide warnings include unwanted substances mixed into a preparation and difficulty confirming the active ingredient. FDA also warns that the body’s defense system may react to certain peptides. These warnings concern particular peptides and ways of taking them, such as by injection.
The immune system is the body's defense system. An immune reaction means it may treat an injected substance as an intruder. Ask which concern applies to the proposed product and what is known about it. Avoid turning a general statement about peptides into a reassuring answer about a specific preparation.
FDA describes contamination and incorrect amounts of active ingredient as serious quality problems that poor compounding can cause.
- What quality questions apply to this preparation?
- Who would answer a question about its contents?
- What uncertainties need to be discussed before a decision?
Look for a clear prescription and source
Dispensing a prescription-only medicine requires an order from a licensed practitioner under the federal law checked in September 2026.
FDA has noted a gap in some online compounded-drug purchases: the recipient may not know the identity of the business doing the preparation.
Take the pharmacy's actual name to its state board record for a check. The license chapter covers that process. Keep the product name and pharmacy answer with the proposed plan, so you are asking about the same thing throughout the conversation.
- Who prepares and dispenses the medicine?
- How can that pharmacy be reached with a question?
- Who takes responsibility for follow-up about the care plan?
Do not borrow storage instructions
Storage conditions differ by product: some peptide medicines require refrigeration while others have room-temperature label directions.
Have the pharmacist talk through the written directions belonging to that preparation. If instructions from different places disagree, take that difference back to the pharmacist and the person who prescribed it. Do not use a general web page to work out a replacement set of instructions.
FDA says a compounded product may lack important labeling information that accompanies an approved medicine.
- What written instructions belong to this preparation?
- Who can clarify a missing or unclear instruction?
- How would a delivery or packaging concern be handled?
Know when to seek urgent help
Anaphylaxis, in MedlinePlus's description, is a rapid allergic reaction that threatens life; severe signs can include breathing difficulty and a swollen tongue or face.
MedlinePlus's directions for severe anaphylaxis symptoms are to call the emergency number, 911, or seek the nearest emergency room.
For an overdose or a mistake with medicine, Poison Control offers confidential help at no cost, around the clock.
These are routes to help, not a checklist for deciding that a reaction is harmless. This site does not assess symptoms. Keep urgent concerns out of the notes feature; it does not send anything to a health professional.
- Use the appropriate help route for the concern.
- Keep the medicine and pharmacy information available to discuss.
- Ask the treating professional how later questions will be handled.
Report a medicine problem
MedWatch lets people receiving care send FDA a medicine-problem report without a fee, and it also accepts reports from other consumers and health professionals.
FDA cautions that an event report cannot establish cause or measure how frequently the reported problem occurs.
The source guide includes the reporting page and the urgent-help reading used here. A report and a care conversation do different jobs. Use the care route for an assessment of your situation and the reporting route to tell FDA about the product problem.